Can Delhi Govt. Administer Covaxin's 2nd Dose To All Eligible Persons In 18-44 Age Group Within 6 Weeks Of Their 1st Dose?: Delhi High Court
3 years, 6 months ago

Can Delhi Govt. Administer Covaxin's 2nd Dose To All Eligible Persons In 18-44 Age Group Within 6 Weeks Of Their 1st Dose?: Delhi High Court

Live Law  

The Delhi High Court on Wednesday asked the Delhi Government as to whether it will be in a position to administer the Covaxin's second dose to all willing and eligible persons in 18 to 44 age group, in the NCT of Delhi, before the expiry of six weeks period from the date of their having received the first dose.The Bench of Justice Rekha Palli was hearing the plea filed by the persons. The Delhi High Court on Wednesday asked the Delhi Government as to whether it will be in a position to administer the Covaxin's second dose to all willing and eligible persons in 18 to 44 age group, in the NCT of Delhi, before the expiry of six weeks period from the date of their having received the first dose. The Bench of Justice Rekha Palli was hearing the plea filed by the persons who fall within the age group of 18 to 44 years and have already received first dose of the 'Covaxin' vaccine. The grievance raised by the petitioners was that though they are now already eligible for the second dose of the vaccine, i.e., after four weeks of having received the first dose of Covaxin, yet, the Delhi Government admittedly not administering them the second dose despite their requests Issuing the notice, the Court asked the Delhi Government's counsel to obtain instructions as to whether it will be in a position to administer the second dose of Covaxin to all willing and eligible persons in the age group of 18 to 44 years, in the NCT of Delhi, before the expiry of six weeks period from the date of their having received the first dose.

Delhi Vaccination Court Age Delhi High Court Group Centre Persons Dose Covaxin Six Weeks Period  covaxins  vaccination  weeks  court  high  govt  dose  eligible  age  group  received  second  delhi  persons  policy

History of this topic

The right way to counter a poor Covaxin safety study
4 months, 3 weeks ago

The right way to counter a poor Covaxin safety study

The Hindu  

It took all of five days for the Indian Council of Medical Research to strongly criticise the poor design of the long-term safety study of Covaxin by researchers from the Banaras Hindu University, Varanasi. A publication failure that is glaring Three years after the interim data were posted as a preprint, Bharat Biotech and ICMR are yet to publish any …

Not Permissible To Take One Dose Of Covishield And Another Of Covaxin: Centre To Delhi High Court
1 year, 10 months ago

Not Permissible To Take One Dose Of Covishield And Another Of Covaxin: Centre To Delhi High Court

Live Law  

The Central Government has informed the Delhi High Court that it is not permissible for an individual to take first dose of Covishield and second dose of Covaxin. Central Government’s standing counsel Anurag Ahluwalia told Justice Prathiba M Singh that mixing of two COVID-19 vaccines is not permissible for the first and second dose. The court was hearing a plea …

Nasal vaccines to roll out in private hospitals soon
2 years ago

Nasal vaccines to roll out in private hospitals soon

Hindustan Times  

A new coronavirus vaccine used as a nasal spray will only be available at private health facilities and the Co-WIN platform was set to be tweaked on Friday to allow people to immediately begin booking shots, people aware of the matter said on Friday. On Thursday, India’s technical expert committee on immunization— National Technical Advisory Group on Immunisation —recommended the …

Government Not Liable To Compensate For Deaths Due To COVID Vaccination : Centre Tells Supreme Court
2 years ago

Government Not Liable To Compensate For Deaths Due To COVID Vaccination : Centre Tells Supreme Court

Live Law  

The Government cannot be held liable to compensate for the deaths occurring due to the administration of COVID-19 vaccines, said the Central Government in an affidavit filed before the Supreme Court.Responding to a petition filed by parents of two girls who died due to the adverse effects of Covishield vaccine, the Union Government submitted that : "The vaccines in use …

After Centre Says 200-Crore COVID Vaccinations Crossed, Delhi High Court Disposes Of PIL Seeking Door-to-Door Inoculation
2 years, 2 months ago

After Centre Says 200-Crore COVID Vaccinations Crossed, Delhi High Court Disposes Of PIL Seeking Door-to-Door Inoculation

Live Law  

Following the Centre's submission that more than 200 crore COVID-19 vaccine doses have been administered across the country, the Delhi High Court has disposed of a Public Interest Litigation seeking a helpline for assistance of those registering for inoculation.A bed-ridden senior citizen had approached the court last year, stating she was at a high risk of getting exposed to the …

COVID-19: Delhi High Court Closes Plea Challenging Centre's Permission For Clinical Trials Of Covaxin Among 2-18 Yrs Old
2 years, 3 months ago

COVID-19: Delhi High Court Closes Plea Challenging Centre's Permission For Clinical Trials Of Covaxin Among 2-18 Yrs Old

Live Law  

The Delhi High Court has disposed of a plea filed during the second wave of COVID-19 against Centre's permission for conducting Phase II and III clinical trials of Covaxin in the age group of 2 to 18 years. A division bench comprising of Chief Justice Satish Chandra Sharma and Justice Subramonium Prasad took note of the Supreme Court's judgment in …

Corbevax as Covid booster for adults from August 12. Check details
2 years, 4 months ago

Corbevax as Covid booster for adults from August 12. Check details

India Today  

In a boost to India’s fight against coronavirus, the government gave nod to Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Announcing the decision, Union Health minister Mansukh Mandaviya said, “Further Strengthening India's arsenal against Covid-19, Ministry of Health and Family Welfare approves Corbevax as precaution dose for those …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

Deccan Chronicle  

New Delhi: The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield …

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report
2 years, 4 months ago

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report

Live Mint  

The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, news agency PTI has reported on 10 August citing official sources. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India Today  

The government has approved Biological E's Corbevax as a precautionary dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precautionary dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for …

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients
2 years, 4 months ago

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients

News 18  

The Centre has approved Biological E’s Corbevax as a Covid-19 precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Union Health Secretary Rajesh Bhushan said, “Corbevax will be available as precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India TV News  

Highlights Biological E's Corbevax has been approved as a booster or precaution dose. Covid vaccination: Biological E's Corbevax has been approved as a booster or precaution dose for those above the age of 18, and those who are fully vaccinated with either Covishield or Covaxin. "Corbevax will be considered as a precaution dose after completion of six months or 26 …

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon
2 years, 4 months ago

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon

News 18  

The Union health ministry is expected to soon approve Biological E’s Corbevax as a precaution dose for people above 18 years who are double vaccinated with either Covishield or Covaxin, official sources said on Tuesday. “Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose …

Go For More Tests, Faster Vaccination: Worried by Uptick in Covid Graph, Centre's Advisory to 7 States
2 years, 4 months ago

Go For More Tests, Faster Vaccination: Worried by Uptick in Covid Graph, Centre's Advisory to 7 States

News 18  

Ramp up testing, promote Covid-appropriate behaviour and increase the pace of vaccination, the Centre has told Delhi and six states amid a spike in coronavirus cases, especially ahead of the festive season. The state must also closely monitor districts reporting higher cases, positivity rates and clusters to prevent further spread of infection and effective case management,” he stressed in the …

Adults may get different vaccine as booster shot instead of Covishield, Covaxin
2 years, 4 months ago

Adults may get different vaccine as booster shot instead of Covishield, Covaxin

Live Mint  

As the government has continued to emphasize Covid booster doses due to the rising number of cases, a panel has recommended a different vaccine for Indian adults. Government panel National Technical Advisory Group on Immunisation has recommended Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin. "Corbevax may be considered for a third/precaution …

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre
2 years, 5 months ago

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre

Firstpost  

Minister of State for Health Bharati Pravin Pawar said as on 19 July, 2022, a total of 200.34 crore COVID-19 vaccine doses have been administered to beneficiaries above 12 years of age in the country New Delhi: India has supplied 23.9 crore doses of coronavirus vaccine to 101 countries and UN entities in the form of grant, commercial export, or …

PM Modi hails India\'s 200 crore COVID vaccination feat
2 years, 5 months ago

PM Modi hails India\'s 200 crore COVID vaccination feat

Deccan Chronicle  

New Delhi: India crossed the milestone of administering 200 crore Covid-19 vaccine doses at around Sunday noon, almost one-and-a-half years after starting the drive in January 2021. The administration of 200 crore doses includes 101.9 crore doses as the first jab, while 92.6 crore doses as the second and 5.49 crore as precaution dose. As many as 71 per cent …

’Only 10% got Covid-19 booster dose’: CM Arvind Kejriwal’s appeal to Delhi
2 years, 5 months ago

’Only 10% got Covid-19 booster dose’: CM Arvind Kejriwal’s appeal to Delhi

Live Mint  

Delhi Chief Minister Arvind Kejriwal on Sunday appealed to the people to get their Covid-19 precaution doses while highlighting that only around 10% people have done it so far. A total of 1.81 crore have been given first dose and 1.53 crore have received both doses, the Delhi chief minister said while emphasising that Delhi has capacity to administer one …

Kejriwal urges Delhiites to get Covid precaution dose, says 'will set up vaccination in schools'
2 years, 5 months ago

Kejriwal urges Delhiites to get Covid precaution dose, says 'will set up vaccination in schools'

India TV News  

Highlights Delhi Chief Minister Arvind Kejriwal on Sunday urged Delhiites to get the precaution dose. Delhi Covid 19 news: Delhi Chief Minister Arvind Kejriwal on Sunday urged Delhiites to get the precaution dose against Covid 19 saying only around 10 per cent of people has done so far in the city. He also urged parents to get their children aged …

India's cumulative Covid-19 vaccination nears 200 crore
2 years, 5 months ago

India's cumulative Covid-19 vaccination nears 200 crore

India Today  

The cumulative Covid-19 vaccine doses administered in the country neared the 200-crore mark on Saturday, the Union health ministry said. Over 14.94 lakh precaution doses of COVID-19 vaccines were given to people in the 18-59 age group till 10 pm, with the majority administered for free under the government's special 75-day drive 'COVID Vaccination Amrit Mahotsav'. The next phase of …

India Set to Achieve Milestone of 200 Crore Covid Vaccinations
2 years, 5 months ago

India Set to Achieve Milestone of 200 Crore Covid Vaccinations

News 18  

India is on the brink of administering 200 crore Covid-19 vaccine doses. Before India’s new milestone is achieved in what is being called the “largest vaccine drive” by the central government, union health minister Mansukh Mandaviya tweeted saying history was about to be created under the leadership of Prime Minister Narendra Modi. The countdown to two billion doses began earlier …

Over 13.3 lakh precaution doses of Covid vaccines administered to beneficiaries in 18-59 age group
2 years, 5 months ago

Over 13.3 lakh precaution doses of Covid vaccines administered to beneficiaries in 18-59 age group

India TV News  

Over 13.3 lakh precaution doses of COVID-19 vaccines were administered to beneficiaries in the age group of 18-59 years till 10 pm on Friday, with a majority of those being free under a special 75-day drive launched by the government. The "COVID Vaccination Amrit Mahotsav" to provide free precaution doses of the vaccines to everyone aged 18 years and above …

DC Edit | A good move, as Covid cases up
2 years, 5 months ago

DC Edit | A good move, as Covid cases up

Deccan Chronicle  

The decision of the Union government to push the vaccination programme further against Covid-19 by making the precaution dose free for those who are aged above 18 years has come not one day sooner. That only one per cent of the eligible population aged between 18 and 59 has got the precaution dose calls on the government to redouble its …

Over 19,000 Lodged in Delhi Prisons, Only 603 Took Covid Precaution Doses: Data
2 years, 5 months ago

Over 19,000 Lodged in Delhi Prisons, Only 603 Took Covid Precaution Doses: Data

News 18  

The third dose of COVID-19 vaccine has been administered to just about 600 out of over 19,000 inmates lodged in Delhi prisons, the authorities said on Thursday, attributing “unwillingness” and “non-eligibility” for the low coverage. According to data accessed by PTI, 28,902 Covid vaccine doses have been administered to inmates of all 16 central jails housed in Tihar, Mandoli and …

Free Covid booster doses will create healthier country: PM Modi
2 years, 5 months ago

Free Covid booster doses will create healthier country: PM Modi

India Today  

Prime Minister Narendra Modi on Wednesday said the government's decision to administer free precautionary doses of Covid-19 vaccines to all citizens aged above 18 will further India's vaccination coverage and create a healthier country. As part of 'Azadi Ka Amrit Mahotsav' celebrations, free precautionary doses of Covid-19 vaccines will be administered to all citizens above the age of 18 at …

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres
2 years, 5 months ago

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres

The Hindu  

As part of the Azadi Ka Amrit Mahotsav celebrations, free precaution doses of COVID-19 vaccines will be available for all citizens above 18 years of age at government vaccination centres from July 15 for 75 days, Anurag Singh Thakur, Union Minister of Information and Broadcasting, announced on July 13, following a meeting of the Union Cabinet. India’s cumulative COVID-19 vaccination …

Govt to provide free Covid booster doses for people in 18-59 age group from July 15
2 years, 5 months ago

Govt to provide free Covid booster doses for people in 18-59 age group from July 15

India TV News  

Highlights The government has announced that it will provide free Covid booster doses Free booster shots will be available for people in age group 18-59 years The announcement came as India is celebrating 75 years of Independence Covid booster dose: The Modi government on Wednesday announced that free Covid booster shots will be given to people in the age group …

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years
2 years, 5 months ago

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years

News 18  

The NTAGI's Standing Technical Sub-Committee approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday. Data of Biological E's Corbevax and Bharat Biotech's Covaxin for children aged between five and 12 years were reviewed in the STSC meeting held on June 16 and members decided that the vaccines …

Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here
2 years, 5 months ago

Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here

Live Mint  

Biological E's Corbevax and Bharat Biotech's Covaxin on July 8 received the nod from the National Technical Advisory Group on Immunisation's Standing Technical Sub-Committee for use among children aged between 5-12 years. The Drugs Controller General of India granted emergency use authorisation to the Biological E's Corbevax for 5-12 year old and Bharat Biotech's Covaxin for minors belonging to the …

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years
2 years, 5 months ago

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years

Live Mint  

The Serum Institute Of India's Covid-19 vaccine Covovax has been approved on Tuesday by the Drugs Controller General of India for children between the age group of 7 and 12 years. The DCGI's nod for restricted emergency use in children came after the subject expert committee on Covid-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax …

Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI
2 years, 5 months ago

Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI

The Hindu  

Allowing Biological E’s Corbevax as a booster for those fully vaccinated against COVID-19 with either Covishield or Covaxin is likely to be considered by the NTAGI, which is scheduled to meet on Tuesday, sources said. “The National Technical Advisory Group on Immunisation will discuss allowing Corbevax, which has been cleared by the DCGI, as a booster for those fully vaccinated …

Govt Panel Recommends Emergency Approval for SII's Covovax for 7-11 Year Olds
2 years, 6 months ago

Govt Panel Recommends Emergency Approval for SII's Covovax for 7-11 Year Olds

News 18  

An expert panel of India's central drug authority on Friday recommended granting emergency use authorisation to Serum Institute's Covovax for children aged 7 to 11 years, official sources said. "The Subject Expert Committee on Covid-19 of the CDSCO deliberated on the EUA application of SII and recommended granting emergency use authorisation for Covovax for children aged 7 to 11 years," …

Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat Biotech
2 years, 6 months ago

Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat Biotech

The Hindu  

Bharat Biotech International Limited, on Friday, announced that COVID-vaccine Covaxin has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study. The company in its press release said that Bharat Biotech had conducted phase II/III, open-label, and multi-centre study to evaluate the safety, reactogenicity, and immunogenicity Covaxin in healthy children and adolescents in 2-18 years …

Covaxin safe, well-tolerated in 2-18 years age-group, announces Bharat Biotech
2 years, 6 months ago

Covaxin safe, well-tolerated in 2-18 years age-group, announces Bharat Biotech

Firstpost  

The clinical trial conducted in the paediatric population between June 2021 to September 2021 has shown safety, less reactogenic, and robust immunogenicity Hyderabad: Bharat Biotech International Limited on Friday announced that its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in paediatric subjects in phase II/III study. Bharat Biotech had conducted phase II/III, open-label, and multi-centre …

Vaccination advisory group recommends reducing COVID-19 booster dose gap to 6 months
2 years, 6 months ago

Vaccination advisory group recommends reducing COVID-19 booster dose gap to 6 months

The Hindu  

The Standing Technical Sub-Committee of the NTAGI on Thursday recommended reducing the gap between the second and precaution doses of COVID-19 vaccines from the current nine to six months, official sources said. The government advisory panel, which met on Thursday, also reviewed the findings of a study by the Christian Medical College in Vellore on the feasibility of allowing as …

NTAGI to Review Covaxin, Corbevax Data for 6-12 Yrs Thursday, Discuss Reducing Booster Dose Gap
2 years, 6 months ago

NTAGI to Review Covaxin, Corbevax Data for 6-12 Yrs Thursday, Discuss Reducing Booster Dose Gap

News 18  

Government advisory panel NTAGI will meet on Thursday to review data on Covaxin and Corbevax vaccines for the 6-12 age group and also deliberate on reducing the gap between the second and precaution doses from the current nine to six months. The agenda for the NTAGI's Standing Technical Sub-Committee meeting includes a discussion on a study by the CMC Vellore …

Mix and match of Covid vaccine for booster shots unlikely to be allowed: Report
2 years, 7 months ago

Mix and match of Covid vaccine for booster shots unlikely to be allowed: Report

Live Mint  

The government may not allow the administration of a precaution Covid-19 dose that is different from the one used for primary vaccination, reported news agency PTI, quoting sources, on Thursday. This comes in light of a recent study by the Christian Medical College Vellore, which showed that a booster dose of Covishield after primary vaccination with Covaxin gives 6 to …

Gap Between 2nd Covid Vaccine, Booster Dose Reduced To 3 Months For Those Travelling Abroad
2 years, 7 months ago

Gap Between 2nd Covid Vaccine, Booster Dose Reduced To 3 Months For Those Travelling Abroad

ABP News  

New Delhi: The government has now reduced the gap between second Covid-19 vaccine jab and booster dose to a minimum of 90 days for those travelling abroad, news agency PTI reported quoting official sources on Wednesday. Those who need to travel overseas can take the booster dose of Covid vaccine as required by the country they are travelling to before …

Biological E seeks EUA of Corbevax as booster for Covishield, Covaxin recipients
2 years, 7 months ago

Biological E seeks EUA of Corbevax as booster for Covishield, Covaxin recipients

Live Mint  

Hyderabad-based Biological E has submitted an application to India's drug regulator, seeking emergency use authorisation for its Covid-19 vaccine Corbevax as a booster dose for adults who have been given two doses of either Covishield or Covaxin, reported news agency PTI, quoting sources. “We are now submitting the marketing authorization application for grant of permission Corbevax for restricted use in …

India Likely to Reduce Gap Between 2nd Covid Vaccine Shot, Booster Dose for Those Flying Abroad
2 years, 7 months ago

India Likely to Reduce Gap Between 2nd Covid Vaccine Shot, Booster Dose for Those Flying Abroad

News 18  

India may reduce the gap between the second Covid-19 vaccine shot and the precautionary third dose from nine to six months for citizens who are scheduled to travel abroad, especially to countries that have made it compulsory for travelers to produce their booster certificates. According to the advisory issued by the Union Ministry of Health and Family Welfare, the gap …

Jabs for Kids, Reducing Gap Between Doses for Those Travelling Abroad on Agenda as NTAGI Meets Today
2 years, 7 months ago

Jabs for Kids, Reducing Gap Between Doses for Those Travelling Abroad on Agenda as NTAGI Meets Today

News 18  

As India witnesses a surge in coronavirus cases once again, the Covid-19 working group of the National Technical Advisory Group on Immunisation will meet at noon on Wednesday to discuss reducing the gap between the second dose and the precaution dose for people traveling abroad as well as vaccinations for 5-12 and 6-12 age groups. Last week, India’s drug regulator …

NTAGI to Discuss Early Administration of Precaution Dose to Those Travelling Abroad
2 years, 7 months ago

NTAGI to Discuss Early Administration of Precaution Dose to Those Travelling Abroad

News 18  

The NTAGI will discuss on Tuesday whether to allow early administration of the precaution dose of COVID-19 vaccine to those travelling abroad for education, employment, sporting events and business commitments. The advisory panel is also likely to deliberate on reducing the gap between the second dose of COVID-19 vaccine and the precaution dose from the current nine months to six …

SII's Covid Vaccine Covovax Now Available for 12-17 Age Group at Private Centres
2 years, 7 months ago

SII's Covid Vaccine Covovax Now Available for 12-17 Age Group at Private Centres

News 18  

Children aged 12 to 17 years can now get the Serum Institute's coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal, official sources said on Monday. "Those aged 12-17 age group can now opt for Covovax shot at private hospitals. India's drug regulator had approved Covovax for restricted use in emergency situations …

No Haste In Granting Emergency Use Authorization To Covaxin & Covishield: Supreme Court
2 years, 7 months ago

No Haste In Granting Emergency Use Authorization To Covaxin & Covishield: Supreme Court

Live Law  

In its judgment holding that the policy of the Union Government on COVID-19 vaccination policy is reasonable, the Supreme Court rejected the contention that restricted emergency use approvals had been granted to COVISHIELD and COVAXIN in haste, without thorough review of the relevant data.The court observed that the challenge to the procedures adopted by the expertbodies while granting. "However, it …

No one can be forced to get vaccinated, rules Supreme Court amid Covid surge
2 years, 7 months ago

No one can be forced to get vaccinated, rules Supreme Court amid Covid surge

India Today  

In an important ruling, the Supreme Court made it clear that no individual can be forced to take any vaccination, but stated that the government can impose some restrictions in the interest of the community. A bench of Justices L Nageswara Rao and B R Gavai delivered the judgement on the plea challenging mandatory Covid-19 vaccine mandates as unconstitutional, saying, …

Nobody can be forced to undergo COVID-19 vaccinations: SC
2 years, 7 months ago

Nobody can be forced to undergo COVID-19 vaccinations: SC

Deccan Chronicle  

New Delhi: The Supreme Court on Monday said that no person can be forced to get vaccinated against COVID-19 and asked the Centre to make public the effect of such an immunisation. Regarding segregation of vaccine trial data, subject to privacy of individuals, all trials conducted and to be subsequently conducted, all data must be made available to the public …

No restrictions on unvaccinated individuals; no one can be forced to take jab: Supreme Court
2 years, 7 months ago

No restrictions on unvaccinated individuals; no one can be forced to take jab: Supreme Court

India TV News  

Highlights The current COVID-19 vaccine policy cannot be said to be manifestly arbitrary and unreasonable Unvaccinated individuals cannot be denied public access, till numbers are low The apex court also directed the Union of India to publish reports on adverse events of vaccines The Supreme Court on Monday said that no person can be forced to get vaccinated against COVID-19 …

SEC seeks more data from Serum Institute of India over COVID vaccine 'Covovax' for 7-12 age group: Sources
2 years, 7 months ago

SEC seeks more data from Serum Institute of India over COVID vaccine 'Covovax' for 7-12 age group: Sources

India TV News  

Highlights DCGI subject expert committee on April 29 sought more data from SII on Covovax vaccine SEC has sought more data for Covovax vaccine for 7-12 years age group Covovax has already been recommended by DCGI for children above 12 years of age Coronavirus vaccine: The Drugs Controller General of India's subject expert committee on Friday sought more data from …

In haste: The Hindu Editorial on vaccinating children against COVID-19
2 years, 7 months ago

In haste: The Hindu Editorial on vaccinating children against COVID-19

The Hindu  

The emergency use authorisation granted on April 26 to two COVID-19 vaccines — Corbevax for children 5-11 years, and Covaxin for children 6-11 years — is one more instance where the Indian drug regulator has acted in haste. Even if the EUA granted to Covaxin in January 2021 despite no safety and efficacy data of the phase-3 trial is condoned …

Gap Between 2nd Dose of Covid Jab, Precaution Dose to Be Reduced to 6 Months Soon
2 years, 7 months ago

Gap Between 2nd Dose of Covid Jab, Precaution Dose to Be Reduced to 6 Months Soon

News 18  

The government is likely to soon reduce the gap between the second dose of COVID-19 vaccine and the precaution dose from the current nine months to six months, official sources said on Wednesday. "Taking into account the scientific evidence and findings of the studies done here and internationally, the gap between the second dose of COVID-19 vaccine and the precaution …

Discover Related